Altimmune (ALT) Invested Capital (2009 - 2026)
Altimmune's Invested Capital was $508.95 million in Q2 2026, up 189.7% from $175.7 million a year earlier and up 59.8% from the prior quarter.
Powered by 
Analysis
Altimmune (ALT) Invested Capital (2009 - 2026) Analysis & Trends
For FY2025, Invested Capital at Altimmune came in at $259.18 million.
- Invested Capital shows a five-year compound annual growth rate of 2.6% (FY2020 to FY2025).
- In earlier years, Invested Capital was $189.87 million in FY2022 (-5.3%) and $200.59 million in FY2021 (-11.9%).
- The Q2 2026 figure marks the highest quarterly Invested Capital in data going back to Q1 2012.
- The best year-over-year quarter for Invested Capital over five years was Q2 2026 (growth of 189.7%); the worst was Q3 2023 (a decline of 26.2%).
- Per Business Quant data, ALT's Invested Capital in the three quarters before Q2 2026 was $318.49 million (Q1 2026), $259.18 million (Q4 2025) and $200.05 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 89.77 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 126.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 76.32 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 98.72 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 45.14 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 68.36 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 39.27 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 151.97 Bn |
| 10 | Altimmune | 377.28 Mn | -764.94 Mn | - | 508.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 508.95 Mn |
| Mar 31, 2026 | 318.49 Mn |
| Dec 31, 2025 | 259.18 Mn |
| Sep 30, 2025 | 200.05 Mn |
| Jun 30, 2025 | 175.70 Mn |
| Sep 30, 2023 | 154.70 Mn |
| Jun 30, 2023 | 171.88 Mn |
| Mar 31, 2023 | 172.13 Mn |
| Dec 31, 2022 | 189.87 Mn |
| Sep 30, 2022 | 209.54 Mn |
| Jun 30, 2022 | 196.06 Mn |
| Mar 31, 2022 | 186.54 Mn |
| Dec 31, 2021 | 200.59 Mn |
| Sep 30, 2021 | 210.83 Mn |
| Jun 30, 2021 | 242.90 Mn |
| Mar 31, 2021 | 248.16 Mn |
| Dec 31, 2020 | 227.70 Mn |
| Sep 30, 2020 | 201.63 Mn |
| Jun 30, 2020 | 81.87 Mn |
| Mar 31, 2020 | 43.69 Mn |
API Access
Altimmune Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();